Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8441617 | European Journal of Cancer | 2016 | 9 Pages |
Abstract
We showed that it is safe to shorten antibiotic treatment to 72 h in selected medium-risk patients with febrile neutropenia, regardless of the neutrophil count. The safety of withholding antibiotics in selected low-risk paediatric cancer patients with febrile neutropenia requires further investigation, using more suitable definitions for safety. Reduction in hospital admissions allows children with cancer more time at home and consequently improves their quality of life.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Karin G.E. Miedema, Wim J.E. Tissing, Floor C.H. Abbink, Lynne M. Ball, Erna M.C. Michiels, Michel J. van Vliet, Wilma Y. de Vries, Willem A. Kamps, Obbe F. Norbruis, Marta Fiocco, Hester A. de Groot-Kruseman, Marianne D. van de Wetering,